Human pharmacokinetics of acyclovir (an antiviral agent) following rapid intravenous injection
- 1 April 1981
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 7 (4) , 399-404
- https://doi.org/10.1093/jac/7.4.399
Abstract
Acyclovir [9-(2 hydroxyethoxymethyl)guanine] an acyclic nucleoside of guanine with potent antiviral activity against the herpes simplex virus both in vitro and topically in man was injected as a bolus intravenously in six healthy volunteers at a mean dose of 0·73 mg/kg after some preliminary slower infusions. Pharmacokinetic data were obtained to aid the design of therapeutic regimens. The drug is excreted principally by the kidneys, principally unchanged, thereby retaining its viricidal activity, and at a rate greater than the glomerular filtration rate. The disposition rate was of the order of 3 h. No signs of intolerance appeared.Keywords
This publication has 4 references indexed in Scilit:
- A sensitive radioimmunoassay for the antiviral agent BW248U [9-(2-hydroxyethoxymethyl)guanine]Analytical Biochemistry, 1979
- EFFICACY OF ACYCLOGUANOSINE (WELLCOME 248U) AGAINST HERPES-SIMPLEX CORNEAL ULCERSThe Lancet, 1979
- 9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes groupNature, 1978
- CSTRIP, a Fortran IV Computer Program for Obtaining Initial Polyexponential Parameter EstimatesJournal of Pharmaceutical Sciences, 1976